218 related articles for article (PubMed ID: 26866523)
1. Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
Carvalhana SC; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):640-4. PubMed ID: 26866523
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
[TBL] [Abstract][Full Text] [Related]
3. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
Bert F; Rindermann A; Abdelfattah MA; Stahmeyer JT; Rossol S
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1246-52. PubMed ID: 27439034
[TBL] [Abstract][Full Text] [Related]
5. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
Waszczuk E; Waszczuk KM; Mulak A; Paradowski L
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):628-32. PubMed ID: 26904976
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
Meffre C; Le Strat Y; Delarocque-Astagneau E; Dubois F; Antona D; Lemasson JM; Warszawski J; Steinmetz J; Coste D; Meyer JF; Leiser S; Giordanella JP; Gueguen R; Desenclos JC
J Med Virol; 2010 Apr; 82(4):546-55. PubMed ID: 20166185
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.
Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV
Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra].
Santos A; Carvalho A; Tomaz J; Rodrigues V; Coxinho L; Bento D; Sá R; Porto A
Acta Med Port; 2000; 13(4):167-71. PubMed ID: 11155483
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hepatitis B in Portugal.
Silva MJ; Valente J; Capela T; Russo P; Calinas F
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):249-258. PubMed ID: 27861252
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study.
Yildirim B; Barut S; Bulut Y; Yenişehirli G; Ozdemir M; Cetin I; Etikan I; Akbaş A; Atiş O; Ozyurt H; Sahin S
Turk J Gastroenterol; 2009 Mar; 20(1):27-30. PubMed ID: 19330732
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
[TBL] [Abstract][Full Text] [Related]
14. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
15. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.
Luo Z; Xie Y; Deng M; Zhou X; Ruan B
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):695-700. PubMed ID: 21617533
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of chronic viral hepatitis markers in 791 recent immigrants in Catalonia, Spain. Screening and vaccination against hepatitis B recommendations].
Valerio L; Barro S; Pérez B; Roca C; Fernández J; Solsona L; Aguilar A; Escribà JM
Rev Clin Esp; 2008 Oct; 208(9):426-31. PubMed ID: 19000469
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C status among health care workers in the five main hospitals in eastern Libya.
Elzouki AN; Elgamay SM; Zorgani A; Elahmer O
J Infect Public Health; 2014; 7(6):534-41. PubMed ID: 25151657
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
